448 related articles for article (PubMed ID: 15720356)
61. Infliximab dependency in children with Crohn's disease.
Duricova D; Pedersen N; Lenicek M; Hradsky O; Bronsky J; Adamcova M; Elkjaer M; Andersen PS; Vitek L; Larsen K; Lukas M; Nevoral J; Wewer V; Munkholm P
Aliment Pharmacol Ther; 2009 Apr; 29(7):792-9. PubMed ID: 19183163
[TBL] [Abstract][Full Text] [Related]
62. Local injection of infliximab in the postoperative recurrence of Crohn's disease.
Biancone L; Cretella M; Tosti C; Palmieri G; Petruzziello C; Geremia A; Calabrese E; Pallone F
Gastrointest Endosc; 2006 Mar; 63(3):486-92. PubMed ID: 16500402
[TBL] [Abstract][Full Text] [Related]
63. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
64. Infliximab use in luminal Crohn's disease.
Richter JA; Bickston SJ
Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
[TBL] [Abstract][Full Text] [Related]
65. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience.
Guidi L; Ratto C; Semeraro S; Roberto I; De Vitis I; Papa A; Marzo M; Parello A; Foglietto G; Doglietto GB; Gasbarrini GB; Fedeli G
Tech Coloproctol; 2008 Jun; 12(2):111-7. PubMed ID: 18545878
[TBL] [Abstract][Full Text] [Related]
66. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
Gisbert JP; Panés J
Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
[TBL] [Abstract][Full Text] [Related]
67. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
Schnitzler F; Fidder H; Ferrante M; Noman M; Arijs I; Van Assche G; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
Gut; 2009 Apr; 58(4):492-500. PubMed ID: 18832518
[TBL] [Abstract][Full Text] [Related]
68. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
69. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
[TBL] [Abstract][Full Text] [Related]
70. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Louis E; Mary JY; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Porcher R; Paintaud G; Piver E; Colombel JF; Lemann M;
Gastroenterology; 2012 Jan; 142(1):63-70.e5; quiz e31. PubMed ID: 21945953
[TBL] [Abstract][Full Text] [Related]
71. Infliximab treatment for anal fistula in patients with Crohn's disease.
Higashi D; Futami K; Egawa Y; Hirano K; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kuroki H; Maekawa T; Ono Y; Matsui T
Anticancer Res; 2009 Mar; 29(3):927-33. PubMed ID: 19414329
[TBL] [Abstract][Full Text] [Related]
72. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
73. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
Hanauer SB; Smith MB
Am J Gastroenterol; 1993 May; 88(5):646-9. PubMed ID: 8480725
[TBL] [Abstract][Full Text] [Related]
74. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668
[TBL] [Abstract][Full Text] [Related]
75. Long-term results of seton drainage on complex anal fistulae in patients with Crohn's disease.
Takesue Y; Ohge H; Yokoyama T; Murakami Y; Imamura Y; Sueda T
J Gastroenterol; 2002; 37(11):912-5. PubMed ID: 12483246
[TBL] [Abstract][Full Text] [Related]
76. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.
Stephens MC; Shepanski MA; Mamula P; Markowitz JE; Brown KA; Baldassano RN
Am J Gastroenterol; 2003 Jan; 98(1):104-11. PubMed ID: 12526944
[TBL] [Abstract][Full Text] [Related]
77. Faecal diversion in the management of perianal Crohn's disease.
Hong MK; Craig Lynch A; Bell S; Woods RJ; Keck JO; Johnston MJ; Heriot AG
Colorectal Dis; 2011 Feb; 13(2):171-6. PubMed ID: 19863597
[TBL] [Abstract][Full Text] [Related]
78. Infliximab: new preparation. A last resort for Crohn's disease.
Prescrire Int; 2000 Dec; 9(50):163-5. PubMed ID: 11475490
[TBL] [Abstract][Full Text] [Related]
79. Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum?
Sciaudone G; Pellino G; Riegler G; Selvaggi F
Eur Surg Res; 2011; 46(4):163-8. PubMed ID: 21454983
[TBL] [Abstract][Full Text] [Related]
80. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
